South Jersey Infectious Disease is a clinical research site located in Somers Point, New Jersey, United States 08244.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
South Jersey Infectious Disease has participated in 41 clinical trials with 7 currently active.
Therapeutic areas: HIV, HIV Infections, SARS-CoV-2 Infection.
Sponsors: Gilead Sciences, BioNTech SE, Golden Biotechnology Corporation.
Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
South Jersey Infectious Disease has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
South Jersey Infectious Disease has 41 clinical trials on record, with 7 currently active. Their work covers HIV, HIV Infections, SARS-CoV-2 Infection.
Yes — South Jersey Infectious Disease holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.